Target intelligence / Profile preview

Plasmodium falciparum acyl-CoA synthetase 11 (PfACS11)

Target
PfACS11
Molecular classification
Enzyme, Acyl-CoA synthetase family
01

Overview

Plasmodium falciparum acyl-CoA synthetase 11 (PfACS11) is an enzyme of the acyl-CoA synthetase family involved in lipid metabolism in the malaria parasite. While not essential for growth in asexual blood stages in vitro, PfACS11 appears to play a significant role in mediating resistance to structurally diverse antimalarial compounds. Mutations in the PfACS11 gene are found in parasites that have acquired low-level resistance to specific antimalarial drugs, likely by decreasing protein stability or altering function. Therefore, while PfACS11 is not a primary drug target, it acts as an important mediator of drug resistance and is relevant in the context of surveillance for emerging antimalarial resistance.

02

Mechanism of action

For interacting drugs: PfACS11 is not the direct target; mutations in its gene enable resistance, possibly by altering protein stability or function. It acts as a resistance mediator rather than a direct point of compound inhibition.

03

Biological functions

Lipid metabolismPossibly involved in fatty acid activation and CoA conjugationMediator of resistance to antimalarial compounds
04

Disease associations

Infection (Malaria)
05

Safety considerations

Potential challenge: Drugs targeting lipid metabolism may inadvertently select for PfACS11-mediated resistance mechanisms
06

Interacting drugs

MMV665924

3 more in the full profile.

07

Biomarkers

Mutations in PfACS11 (e.g., F387V, D648Y, E668K) may serve as biomarkers for emergent resistance to certain antimalarial drugs

Beyond the preview

Go deeper on Plasmodium falciparum acyl-CoA synthetase 11 (PfACS11).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasmodium falciparum acyl-CoA synthetase 11 (PfACS11).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call